Cargando…
2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children
BACKGROUND: Measles virus infection results in immune activation, viral clearance and lifelong immunity. In addition, there is an immunosuppressive state defined by type 2 skewing of CD4(+) T‐cell cytokine production and induction of regulatory T cells with reduced dendritic cell (DC) activation in...
Autores principales: | , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810256/ http://dx.doi.org/10.1093/ofid/ofz360.2327 |
_version_ | 1783462205923000320 |
---|---|
author | Gans, Hayley Wang, Weiqi Rosenberg-Hasson, Yael Zerbo, Ousseny Modaressi, Sharareh Goddard, Kristin Lewis, Ned Bok, Karin Klein, Nicola |
author_facet | Gans, Hayley Wang, Weiqi Rosenberg-Hasson, Yael Zerbo, Ousseny Modaressi, Sharareh Goddard, Kristin Lewis, Ned Bok, Karin Klein, Nicola |
author_sort | Gans, Hayley |
collection | PubMed |
description | BACKGROUND: Measles virus infection results in immune activation, viral clearance and lifelong immunity. In addition, there is an immunosuppressive state defined by type 2 skewing of CD4(+) T‐cell cytokine production and induction of regulatory T cells with reduced dendritic cell (DC) activation in the recovery phase. Studies following measles immunization show conflicting immune profiles. To more robustly interrogate and define specific functional cytokine profiles, this study evaluated cytokine profiles in 12-month old infants before and after primary MMR vaccination. METHODS: Cytokine profiles using luminex assay (62-plex; eBioscience) were measured in 65 infants before and 42 days after MMR vaccination administered at 12 months of age as part of a randomized clinical trial. Mean cytokine percentages of children with increased or decreased concentrations of each cytokine in the post sample compared with the levels in the pre sample were evaluated using Student’s t-test. Cytokines were arranged into dominant CD4+ T-cell type, Th1, Th2, and T regulatory (T(reg)) and those produced by DC. RESULTS: No dominant cytokine pattern emerged following measles immunization, with a balanced profile. The mean percentage of children with increased and decreased concentrations (pg/mL) of signature CD 4+ T-cell Th1 (tumor necrosis factor alpha [TNFa], interferon gamma [IFNg]), Th2 (Interleukin [IL] IL5, IL4, IL13), T(reg) (IL10, transforming growth factor-β TCFb) and DC (IL12P40 and IL12P70) cytokines were equivalent when measured at 42 days after MMR vaccine compared with levels before vaccine (Table 1) (P ≥ 0.05 for all comparisons). CONCLUSION: In contrast to data demonstrating an immune suppression profile following measles disease, measles-containing vaccine did not suppress Th1 CD4+ T-cell and DC cytokines or promote Th2 and T(reg) CD4+ T-cell cytokines measured 42 days after vaccination. The cytokine profile represents one of balance and homeostasis. This study supports the data that show measles vaccine does not cause immunosuppression in healthy infants. [Image: see text] DISCLOSURES: All authors: No reported disclosures. |
format | Online Article Text |
id | pubmed-6810256 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Oxford University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-68102562019-10-28 2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children Gans, Hayley Wang, Weiqi Rosenberg-Hasson, Yael Zerbo, Ousseny Modaressi, Sharareh Goddard, Kristin Lewis, Ned Bok, Karin Klein, Nicola Open Forum Infect Dis Abstracts BACKGROUND: Measles virus infection results in immune activation, viral clearance and lifelong immunity. In addition, there is an immunosuppressive state defined by type 2 skewing of CD4(+) T‐cell cytokine production and induction of regulatory T cells with reduced dendritic cell (DC) activation in the recovery phase. Studies following measles immunization show conflicting immune profiles. To more robustly interrogate and define specific functional cytokine profiles, this study evaluated cytokine profiles in 12-month old infants before and after primary MMR vaccination. METHODS: Cytokine profiles using luminex assay (62-plex; eBioscience) were measured in 65 infants before and 42 days after MMR vaccination administered at 12 months of age as part of a randomized clinical trial. Mean cytokine percentages of children with increased or decreased concentrations of each cytokine in the post sample compared with the levels in the pre sample were evaluated using Student’s t-test. Cytokines were arranged into dominant CD4+ T-cell type, Th1, Th2, and T regulatory (T(reg)) and those produced by DC. RESULTS: No dominant cytokine pattern emerged following measles immunization, with a balanced profile. The mean percentage of children with increased and decreased concentrations (pg/mL) of signature CD 4+ T-cell Th1 (tumor necrosis factor alpha [TNFa], interferon gamma [IFNg]), Th2 (Interleukin [IL] IL5, IL4, IL13), T(reg) (IL10, transforming growth factor-β TCFb) and DC (IL12P40 and IL12P70) cytokines were equivalent when measured at 42 days after MMR vaccine compared with levels before vaccine (Table 1) (P ≥ 0.05 for all comparisons). CONCLUSION: In contrast to data demonstrating an immune suppression profile following measles disease, measles-containing vaccine did not suppress Th1 CD4+ T-cell and DC cytokines or promote Th2 and T(reg) CD4+ T-cell cytokines measured 42 days after vaccination. The cytokine profile represents one of balance and homeostasis. This study supports the data that show measles vaccine does not cause immunosuppression in healthy infants. [Image: see text] DISCLOSURES: All authors: No reported disclosures. Oxford University Press 2019-10-23 /pmc/articles/PMC6810256/ http://dx.doi.org/10.1093/ofid/ofz360.2327 Text en © The Author(s) 2019. Published by Oxford University Press on behalf of Infectious Diseases Society of America. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs licence (http://creativecommons.org/licenses/by-nc-nd/4.0/), which permits non-commercial reproduction and distribution of the work, in any medium, provided the original work is not altered or transformed in any way, and that the work is properly cited. For commercial re-use, please contact journals.permissions@oup.com |
spellingShingle | Abstracts Gans, Hayley Wang, Weiqi Rosenberg-Hasson, Yael Zerbo, Ousseny Modaressi, Sharareh Goddard, Kristin Lewis, Ned Bok, Karin Klein, Nicola 2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children |
title | 2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children |
title_full | 2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children |
title_fullStr | 2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children |
title_full_unstemmed | 2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children |
title_short | 2649. Measles-Containing Vaccination Resulted in a Balanced Cytokine Profile Without Evidence of Immunosuppression in Healthy 12-Month-Old Children |
title_sort | 2649. measles-containing vaccination resulted in a balanced cytokine profile without evidence of immunosuppression in healthy 12-month-old children |
topic | Abstracts |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6810256/ http://dx.doi.org/10.1093/ofid/ofz360.2327 |
work_keys_str_mv | AT ganshayley 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren AT wangweiqi 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren AT rosenberghassonyael 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren AT zerboousseny 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren AT modaressisharareh 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren AT goddardkristin 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren AT lewisned 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren AT bokkarin 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren AT kleinnicola 2649measlescontainingvaccinationresultedinabalancedcytokineprofilewithoutevidenceofimmunosuppressioninhealthy12montholdchildren |